<PAGE>
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
Filed by the Registrant /X/
Filed by a Party other than the Registrant / /
Check the appropriate box:
/ / Preliminary Proxy Statement
/X/ Definitive Proxy Statement
/ / Definitive Additional Materials
/ / Soliciting Material Pursuant to Section 240.14a-11(c) or Section
240.142-12
BAXTER INTERNATIONAL INC.
- --------------------------------------------------------------------------------
(Name of Registrant as Specified In Its Charter)
BAXTER INTERNATIONAL INC.
- --------------------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement)
Payment of Filing Fee (Check the appropriate box):
/X/ $125 per Exchange Act Rules 0-11(c)(1)(ii), 14a-6(i)(1), or 14a-6(i)(2)
/ / $500 per each party to the controversy pursuant to Exchange Act Rule
14a-6(i)(3)
/ / Fee computed on table below per Exchange Act Rules 14a-6(i)(4)
and 0-11
1) Title of each class of securities to which transaction applies:
------------------------------------------------------------------------
2) Aggregate number of securities to which transaction applies:
------------------------------------------------------------------------
3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11:*
------------------------------------------------------------------------
4) Proposed maximum aggregate value of transaction:
------------------------------------------------------------------------
* Set forth the amount on which the filing fee is calculated and state how it
was determined.
/ / Check box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number,
or the Form or Schedule and the date of its filing.
1) Amount Previously Paid:
------------------------------------------------------------------------
2) Form, Schedule or Registration Statement No.:
------------------------------------------------------------------------
3) Filing Party:
------------------------------------------------------------------------
4) Date Filed:
------------------------------------------------------------------------
<PAGE>
Baxter International
Inc. 847.948.2000
One Baxter Parkway
Deerfield, Illinois 60015
[LOGO]
March 22, 1996
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
The 1996 annual meeting of stockholders of Baxter
International Inc. ("Company") will be held in the Grand
Ballroom at the Hyatt Westlake Plaza, in Westlake Village,
California, on Monday, May 6, 1996 at 10:00 a.m. Pacific
Time, for the following purposes:
1. To elect six directors to hold office for three years
(page 3);
2. To ratify the appointment of Price Waterhouse LLP as
independent accountant for the Company in 1996 (page
20);
3. To act on the stockholder proposal relating to
cumulative voting in the election of directors (page
20); and
4. To transact any other business which is properly
presented at the meeting.
Only holders of record of the Company's common stock at the
close of business on March 8, 1996 will be entitled to vote
at the meeting. A list of the stockholders entitled to vote
at the meeting will be kept at Home Savings Bank of America,
Attn: Terry Jones, 248 Hampshire Road, Westlake Village,
California 91360, for the 10-day period before the meeting.
Please mark and sign the enclosed proxy card and return it
promptly in the enclosed envelope, even if you plan to attend
the meeting, to ensure that your vote is counted. If you
attend the meeting and vote by ballot at the meeting, your
proxy will be revoked automatically and only your vote at the
meeting will be counted.
By order of the Board of Directors,
[Signature]
A. GERARD SIECK
SECRETARY
<PAGE>
- --------------------------------------------------------------------------------
[LOGO]
BAXTER INTERNATIONAL INC., ONE BAXTER PARKWAY, DEERFIELD, ILLINOIS 60015,
847.948.2000
- --------------------------------------------------------------------------------
The Board of Directors of Baxter International Inc. ("Company") solicits
your proxy for the annual meeting of stockholders to be held on May 6, 1996.
This proxy statement and the accompanying proxy card are being mailed to
stockholders beginning approximately March 22, 1996.
Because many of the Company's stockholders are unable to attend the annual
meeting in person, the board solicits proxies by mail to give each stockholder
an opportunity to vote on all matters presented at the meeting. Stockholders are
urged to:
(1) read this proxy statement carefully;
(2) specify their choices on each matter by marking the appropriate box on
the enclosed proxy card; and
(3) sign, date and return the card in the enclosed envelope.
There is a place on the enclosed proxy card for stockholders to request
confidential treatment of their votes. If a stockholder requests, inspectors of
election and tabulators will keep the stockholder's vote permanently
confidential and not disclose the vote to anyone other than another inspector or
tabulator. Confidential treatment will not apply when it would not comply with
law or during a proxy contest (neither of which is applicable to this proxy
solicitation).
Only holders of record of the Company's common stock, $1 par value, ("Common
Stock") at the close of business on March 8, 1996, will be entitled to vote. On
that date, approximately 273,957,449 shares of Common Stock were outstanding.
The holders of the Common Stock are entitled to vote as a single class with each
share entitled to one vote. Any stockholder signing a proxy card may revoke or
revise it at any time before the meeting by submitting a new proxy card to the
secretary of the Company or by voting in person at the meeting. Either action
automatically will cancel any proxy card previously signed.
If no specific instructions are given and the proxy card is properly signed
and returned, all shares covered by the proxy card will be voted by the
Company's chairman of the board and chief executive officer or the senior vice
president and general counsel for the election of all of the board's nominees
for directors, for ratification of Price Waterhouse LLP as independent
accountant for 1996, and against the stockholder proposal relating to cumulative
voting in the election of directors. Unless otherwise indicated by the
stockholder, proxy cards also give the Company's chairman and chief executive
officer and its senior vice president and general counsel discretionary
authority to vote all shares of Common Stock represented by the proxy on any
other matter that is properly presented for action at the meeting.
Common Stock credited to a participant in either the Company's Stockholder
Investment Service (dividend reinvestment plan) or an uncertificated share
account of the employee stock purchase plans will be voted in the same manner as
the participant votes the Common Stock standing in his or her name. If a
participant is not a stockholder of record, the custodian, The First Chicago
Trust Company of New York, will vote shares of Common Stock held in such
accounts only in accordance with the participant's instructions.
1
<PAGE>
- --------------------------------------------------------------------------------
Determination of whether a matter specified in the Notice of Annual Meeting
of Stockholders has been approved will be determined as follows. Those persons
will be elected directors who receive a plurality of the shares of Common Stock
present at the annual meeting in person or by proxy and entitled to vote on the
election. Accordingly, directions to withhold authority will have no effect on
the outcome of the vote. For each other matter specified in the Notice of Annual
Meeting of Stockholders, the affirmative vote of a majority of the shares of
Common Stock present at the annual meeting in person or by proxy and entitled to
vote on such matter is required for approval. Abstentions will be considered
shares present in person or by proxy and entitled to vote and will, therefore,
have the effect of a vote against the matter. Broker non-votes will be
considered shares not present for this purpose and will have no effect on the
outcome of the vote. Directions to withhold authority to vote for directors,
abstentions and broker non-votes will be counted for purposes of determining if
a quorum is present for the annual meeting.
- --------------------------------------------------------------------------------
BOARD OF DIRECTORS
The Company's certificate of incorporation divides the Board of Directors
into three classes. Each year, the directors in one class are elected to serve a
three-year term. The Company's certificate of incorporation and bylaws allow the
directors to increase (and decrease) the size of the board, to elect directors
to fill the vacancies created by the increase and to assign the elected
directors to a class. Pursuant to that authority, in November 1995, the Board of
Directors elected Harry M. Jansen Kraemer, Jr. and Lester B. Knight to serve as
directors of the Company until the 1996 and 1997, respectively, annual meetings
of stockholders. Pursuant to the same authority, the Board of Directors elected
Pei-yuan Chia in February 1996 to serve as a director of the Company until the
1998 annual meeting of stockholders and elected Dr. Reed V. Tuckson in March
1996 to serve as a director of the Company until the 1996 annual meeting of
stockholders.
The Board of Directors has nominated Silas S. Cathcart, David W. Grainger,
Martha R. Ingram, Harry M. Jansen Kraemer, Jr., Dr. Reed V. Tuckson and Fred L.
Turner for election as directors at the 1996 annual meeting. All of the nominees
are currently directors of the Company. Each director elected will serve a
three-year term. If any nominee for director becomes unavailable for election,
the number of directors will be reduced. No other candidates are eligible for
election as directors at the 1996 annual meeting. Stockholders who want to
nominate candidates for election as directors at future annual meetings must
comply with procedures in the Company's bylaws. A copy of the bylaws may be
obtained from the secretary of the Company.
William B. Graham, a director of the Company since 1945, retired as senior
chairman and as an active member of the Board of Directors in November 1995. Mr.
Graham has served the Company for more than 50 years in many capacities,
including president, chief executive officer, chairman of the board and senior
chairman. The board expresses its appreciation to Mr. Graham for his outstanding
contributions over his long and extraordinary career with the Company. Upon his
retirement, Mr. Graham was appointed an honorary director with the title of
chairman emeritus.
The chairman and chief executive officer and the senior vice president and
general counsel intend to vote the shares represented by proxies for all of the
board's nominees, except to the extent authority to vote for the nominees is
withheld.
Directors will be elected by a plurality of the votes cast FOR the election
of directors at the annual meeting. This means that the six individuals who
receive the largest number of votes cast will be elected as directors.
2
<PAGE>
- --------------------------------------------------------------------------------
The Board of Directors recommends a vote FOR the election of all of the
nominees for directors.
- --------------------------------------------------------------------------------
ELECTION OF DIRECTORS
(ITEM 1 ON PROXY CARD)
INFORMATION CONCERNING NOMINEES FOR ELECTION AS DIRECTORS
Silas S. Cathcart--Age 69 Director since 1990
Mr. Cathcart is a director of General Electric Company, Illinois Tool Works,
Inc. and The Quaker Oats Company. Mr. Cathcart is also a trustee of Northern
Funds Mutual Fund. From 1985 to 1987, Mr. Cathcart served as a director of the
Company; from 1970 to 1985 he served as a director of American Hospital Supply
Corporation. Mr. Cathcart served as chairman of the board and chief executive
officer of Kidder, Peabody Group Inc., an investment banking firm, from 1988 to
1989, and as president and chief executive officer from 1987 to 1988. From 1972
to 1986, he was chairman of Illinois Tool Works, Inc.
David W. Grainger--Age 68 Director since 1990
Since 1968, Mr. Grainger has been chairman of the board of W. W. Grainger,
Inc., a nationwide distributor of equipment, components and supplies. He joined
W. W. Grainger, Inc. in 1952.
Martha R. Ingram--Age 60 Director since 1987
Since 1995, Ms. Ingram has been the chairman of the board of directors of
Ingram Industries Inc., a diversified transportation and energy company and
distributor of consumer products. She was first elected a director of Ingram
Industries Inc. in 1981. Ms. Ingram also serves as a director of First American
Corporation and Weyerhaeuser Company.
Harry M. Jansen Kraemer, Jr.--Age 41 Director since 1995
Mr. Kraemer has been senior vice president and chief financial officer of
the Company since 1993. Mr. Kraemer previously was the vice president of finance
and operations for a subsidiary of the Company. Prior to that he was employed as
controller, group controller, and president of various divisions of subsidiaries
of the Company.
Reed V. Tuckson, M.D.--Age 45 Director since 1996
Since 1991, Dr. Tuckson, an internist, has been the president of the Charles
R. Drew University of Medicine and Science, a private academic health sciences
university. From 1990 to 1991, he was the senior vice president for programs of
the March of Dimes Birth Defects Foundation. From 1986 to 1990, Dr. Tuckson was
the Commissioner of Public Health for the District of Columbia. Dr. Tuckson also
serves as president of the Association of Minority Health Professional Schools.
Fred L. Turner--Age 63 Director since 1982
Mr. Turner is senior chairman of the board of directors and chairman of the
executive committee of McDonald's Corporation, a restaurant licensor. Mr. Turner
previously was chairman of the board and chief executive officer of McDonald's
Corporation. He joined McDonald's in 1956. Mr. Turner also serves as a director
of Aon Corporation and W. W. Grainger, Inc.
3
<PAGE>
- --------------------------------------------------------------------------------
INFORMATION CONCERNING DIRECTORS CONTINUING IN OFFICE
Pei-yuan Chia--Age 57 Director since 1996
Term expires 1998
Mr. Chia has been a vice chairman of Citicorp, N.A. and Citibank, N.A., its
principal subsidiary, since 1994, a director of Citicorp, N.A. and Citibank,
N.A. since 1993, and responsible for their global consumer business since 1992.
He also is Citibank, N.A.'s senior customer contact for corporate banking
activities in Asia. Between 1974 and 1992, Mr. Chia held various senior
management positions in Citicorp, N.A. and Citibank, N.A. He is a trustee of The
Asia Society and of the New York University Medical Center, both in New York
City. He also serves on the Wharton Graduate Executive Board of the University
of Pennsylvania.
John W. Colloton--Age 65 Director since 1989
Term expires 1997
From 1971 to 1993, Mr. Colloton served as the director of the University of
Iowa Hospitals and Clinics, and since 1993 he has been vice president of the
University of Iowa for Statewide Health Services. Mr. Colloton also serves as a
director of Iowa State Bank & Trust, OncorMed Inc., Mid American Energy Company,
Iowa-South Dakota Blue Cross and Blue Shield (IASD) and the University of
Pennsylvania Medical Center.
Susan Crown--Age 37 Director since 1993
Term expires 1997
Since 1984, Ms. Crown has been a vice president of Henry Crown and Company,
which includes diversified manufacturing operations, real estate and securities.
Ms. Crown also serves as a director of Caribbean International News Corporation,
Illinois Tool Works, Inc. and as a trustee of Northern Funds Mutual Fund.
Mary Johnston Evans--Age 66 Director since 1986
Term expires 1998
Mrs. Evans is a director of Household International, Inc., Sun Company,
Inc., Delta Air Lines, Inc., The Dun & Bradstreet Corporation and Scudder New
Europe Fund.
Frank R. Frame--Age 66 Director since 1992
Term expires 1998
Mr. Frame is an adviser to the board of directors of HSBC Holdings plc., a
financial institution. Between 1976 and 1990, Mr. Frame held various senior
management positions in The Hongkong and Shanghai Banking Corporation Limited, a
financial institution from which he retired in 1990, including group legal
adviser, executive director and deputy chairman. Mr. Frame also serves as
chairman of Wallem Group Limited, deputy chairman of Time Products plc, and
director of Edinburgh Dragon Trust plc, HSBC Global Investment Funds, SICAV, and
The British Investment Trust plc.
Lester B. Knight--Age 37 Director since 1995
Term expires 1997
Mr. Knight has been an executive vice president of the Company since 1992,
and a corporate vice president since 1990, when he was first elected an officer.
4
<PAGE>
- --------------------------------------------------------------------------------
Arnold J. Levine--Age 56 Director since 1994
Term expires 1998
Dr. Levine has been a professor of biology and the chairman of the molecular
biology department at Princeton University since 1984. From 1979 to 1983, Dr.
Levine was a professor of biology and the chairman of the molecular biology
department at State University of New York. Since 1982, Dr. Levine has been the
chairman of the Company's scientific advisory board.
Vernon R. Loucks Jr.--Age 61 Director since 1975
Term expires 1997
Mr. Loucks has been chairman of the Board of Directors since 1987 and chief
executive officer of the Company since 1980. Mr. Loucks was first elected an
officer of the Company in 1971. Mr. Loucks also serves as a director of
Anheuser-Busch Companies, Inc., The Dun & Bradstreet Corporation, Emerson
Electric Co. and The Quaker Oats Company.
Georges C. St. Laurent, Jr.--Age 59 Director since 1992
Term expires 1997
Since 1988, Mr. St. Laurent has been chairman of the board and chief
executive officer of Western Bank, a financial institution. He was first elected
a director of Western Bank in 1987.
Monroe E. Trout, M.D.--Age 64 Director since 1995
Term expires 1998
Dr. Trout was chairman of the board, president and chief executive officer
of American Healthcare Systems, a network of integrated health care systems,
from 1987 to 1994 when he retired. He was elected president and chief executive
officer of American Healthcare Systems in 1986. Dr. Trout also serves as a
director of Cytyc Corporation, Science Applications International Corporation
(SAIC), Gensia, Inc., and The West Company, Inc.
- --------------------------------------------------------------------------------
OPERATION OF THE BOARD OF DIRECTORS
Pursuant to Delaware law, under which the Company is organized, the
Company's business, property and affairs are managed under the direction of the
Board of Directors. During 1995, there were nine meetings of the board. Each
current director attended 75% or more of the meetings of the board held when he
or she was a director and the board committees to which he or she was assigned
as a regular member.
COMMITTEES OF THE BOARD
The Board of Directors has six committees, the duties of which are described
in the Company's bylaws.
The Executive Committee consists of four directors, a majority of whom are
not employees of the Company. The committee may exercise most of the powers of
the Board of Directors, except those reserved to the Board of Directors by the
Company's bylaws or Delaware law. The Executive Committee did not meet in 1995.
The current members of the Executive Committee are Vernon R. Loucks Jr.
(chairman), Silas S. Cathcart, Susan Crown and Fred L. Turner.
5
<PAGE>
- --------------------------------------------------------------------------------
The Audit Committee consists of five directors who are not employees of the
Company. The committee assists the Board of Directors in fulfilling its
responsibility for the Company's accounting and financial reporting practices
and provides a channel of communication between the Board of Directors and the
Company's independent accountant. The Audit Committee met four times in 1995.
The current members of the Audit Committee are Georges C. St. Laurent, Jr.
(chairman), Silas S. Cathcart, Frank R. Frame, Monroe E. Trout and Fred L.
Turner.
The Compensation Committee consists of four directors who are not employees
of the Company. The committee determines compensation for officers, and makes
recommendations to the Board of Directors concerning compensation for the
chairman of the board and chief executive officer. It also exercises the
authority of the Board of Directors relating to the Company's employee benefit
plans. The Compensation Committee met six times in 1995. The current members of
the Compensation Committee are Silas S. Cathcart (chairman), Mary Johnston
Evans, Martha R. Ingram and Georges C. St. Laurent, Jr.
The Finance Committee consists of five directors who are not employees of
the Company. Within limits established in the Company's bylaws, the committee
exercises the authority of the Board of Directors in connection with financial
transactions and assists and advises the Board of Directors regarding the
financial affairs of the Company. The Finance Committee met six times in 1995.
The current members of the Finance Committee are John W. Colloton (chairman),
Pei-yuan Chia, Susan Crown, David W. Grainger and Arnold J. Levine.
The Planning and Organization Committee consists of five directors who are
not employees of the Company. The committee assists and advises the Board of
Directors in connection with board membership, board committee structure and
membership as well as general organization and planning matters. The Planning
and Organization Committee considers director candidates. Under guidelines
followed by the committee, it seeks candidates with high integrity, good
judgment and breadth of experience, among other criteria. Stockholders may
nominate director candidates for election at an annual meeting of stockholders
by providing written notice of such nomination to the secretary of the Company.
The Company's bylaws require the notice to be submitted to the Company 60 to 90
days before the anniversary date of the previous year's annual meeting. The
bylaws also require the notice to include specified information about the
stockholder making the nomination and specified information about the director
candidate, including all information that would be required to be disclosed in a
proxy statement. The Planning and Organization Committee met four times in 1995.
The current members of the Planning and Organization Committee are Fred L.
Turner (chairman), Susan Crown, Mary Johnston Evans, David W. Grainger and
Monroe E. Trout.
The Public Policy Committee consists of five directors who are not employees
of the Company. The committee reviews the policies and practices of the Company
to assure that they are consistent with its social responsibility to employees,
customers and society. The Public Policy Committee met three times in 1995. The
current members of the Public Policy Committee are Martha R. Ingram (chairman),
Pei-yuan Chia, John W. Colloton, Frank R. Frame and Arnold J. Levine.
- --------------------------------------------------------------------------------
COMPENSATION OF DIRECTORS
Cash compensation of non-employee directors consists of a $1,000 fee for
each board and each committee meeting attended. Members of committees receive an
annual retainer of $3,000, and chairmen of committees receive an additional
annual retainer of $4,000; except that members
6
<PAGE>
- --------------------------------------------------------------------------------
of the Executive Committee do not receive any annual retainer for their
Executive Committee membership. Directors may elect to defer payment of all or a
part of their cash compensation. Employee directors are not compensated
separately for their board or committee activities.
Effective in May 1995, the Board of Directors amended the restricted stock
plan for non-employee directors ("Director Stock Plan") to provide directors
with less cash compensation and more Common Stock. The amendments to the
Director Stock Plan reflect the directors' commitment to aligning their
interests more closely with the interests of all of the Company's stockholders.
Pursuant to those amendments, each non-employee director receives 3,000
restricted shares of Common Stock upon election or re-election to a three-year
term. This restricted stock award replaced a $25,000 annual cash retainer that
previously was payable to each non-employee director for board membership.
As part of the transition to the new compensation program, each non-employee
director in office at the beginning of 1995 received $12,500 (one-half of the
discontinued $25,000 annual cash retainer) for service during the first half of
1995. Also, as part of the transition to the new compensation program,
non-employee directors who were not re-elected at the 1995 annual meeting,
because they had two years or one year remaining on their current terms,
received 2,000 or 1,000 restricted shares of Common Stock, respectively, in May
1995. The restricted shares described in this paragraph and the preceding
paragraph vest over the directors' terms of office.
Each non-employee director receives an additional 1,000 restricted shares of
Common Stock upon election or re-election to a three-year term, pursuant to the
amended Director Stock Plan. This fixed number of shares replaces the variable
number of shares which would otherwise have been calculated and granted in
accordance with the Director Stock Plan before it was amended. These restricted
shares vest at the expiration of the director's term of office.
Each non-employee director who retires at age 65 or after, with at least
five years of board service, will receive upon retirement 1,000 restricted
shares of Common Stock for each of the director's full years of service as a
non-employee director, pursuant to the amended Director Stock Plan. This
restricted stock award replaced the annual cash payment which otherwise would
have been paid for a period of time equal to the director's full years of
service as a non-employee director. This restricted stock award applies to all
directors who retire on or after the May 1995 effective date of the amendments.
These restricted shares vest six months after the grant date. Each non-employee
director is also eligible for medical benefits and life insurance benefits.
Medical benefit payments in 1995 totaled $14,961 for all non-employee directors.
No non-employee director life insurance benefits were paid in 1995.
Grants of restricted stock awarded under the Director Stock Plan vest as
described above, unless specified corporate control changes occur. Until vested,
the restricted stock may not be transferred or sold by the director. During the
restriction period, the director has all of the other rights of a stockholder,
including the right to receive dividends and vote the shares.
In lieu of the non-employee director cash compensation and retirement
benefits described above, the Company entered into consulting and pension
agreements with William B. Graham in 1985 and 1987, respectively. Under the
consulting agreement, Mr. Graham received $250,000 per year until the agreement
terminated in November 1995 when he retired as senior chairman and as an active
member of the Board of Directors. Under the pension agreement, Mr. Graham
receives a non-qualified supplemental retirement benefit equal to the benefit he
would have received under the Company's employee pension plan if he had 10
additional years of pension plan participation.
7
<PAGE>
- --------------------------------------------------------------------------------
In addition to the non-employee director compensation and benefits described
above, Dr. Arnold J. Levine receives an annual consulting fee for his services
as chairman of the Company's scientific advisory board. The total consulting fee
paid to Dr. Levine in 1995 was $29,250, and it is expected to be approximately
the same in 1996. The members of the Company's scientific advisory board also
receive, from time to time, stock option grants which give them the opportunity
to purchase Common Stock for a limited period of time at the closing price of
the Common Stock on the date of grant. Dr. Levine did not receive any stock
option grants in 1995, but he has the opportunity to purchase 1,570 shares of
Common Stock pursuant to a stock option grant which he and the other members of
the Company's scientific advisory board received previously. The exercise price
of this stock option grant, which expires on September 19, 1997, is $33.32 per
share.
- --------------------------------------------------------------------------------
COMPENSATION OF NAMED EXECUTIVE OFFICERS
GENERAL
The following table shows, for the years ended December 31, 1995, 1994, and
1993 the compensation provided by the Company and its subsidiaries to the
chairman and chief executive officer and the five next most highly compensated
executive officers in all capacities in which they served.
SUMMARY COMPENSATION TABLE
<TABLE>
<CAPTION>
LONG TERM COMPENSATION
ANNUAL COMPENSATION -------------------------------
---------------------------------- AWARDS
OTHER ---------------------- PAYOUTS ALL
ANNUAL RESTRICTED SECURITIES ------- OTHER
COMPEN- STOCK UNDERLYING LTIP COMPEN-
SALARY BONUS SATION AWARD(S) OPTIONS PAYOUTS SATION
NAME AND PRINCIPAL POSITION YEAR ($)(1) ($)(1) ($)(2) ($)(3) (#)(4) ($)(5) ($)(6)
<S> <C> <C> <C> <C> <C> <C> <C> <C>
- -----------------------------------------------------------------------------------------------------------------
VERNON R. LOUCKS JR. 1995 $751,000 $800,000 $321,763 -0- 110,800 -0- $49,110
Chairman of the Board and Chief 1994 $580,100 $800,000 $213,195 -0- 350,000 -0- $35,445
Executive Officer 1993 $693,231 $500,000 $209,311 -0- 88,800 -0- $46,342
- -----------------------------------------------------------------------------------------------------------------
LESTER B. KNIGHT 1995 $367,000 $350,000 $12,134 $ 23,139 44,800 -0- $23,241
Executive Vice President 1994 $324,938 $400,000 $ 5,526 $ 288,958 200,000 -0- $17,477
1993 $291,114 $250,000 (excl) -0- 27,000 -0- $18,789
- -----------------------------------------------------------------------------------------------------------------
TONY L. WHITE (7) 1995 $367,000 $300,000 $18,734 -0- 44,800 -0- $24,572
Executive Vice President 1994 $327,950 $400,000 $24,196 $ 237,023 200,000 -0- $20,026
1993 $311,908 $325,000 (excl) -0- 27,000 -0- $19,557
- -----------------------------------------------------------------------------------------------------------------
HARRY M. JANSEN KRAEMER, JR. 1995 $288,577 $240,000 $ 5,634 -0- 35,400 -0- $15,504
Senior Vice President 1994 $249,615 $225,000 (excl) $ 262,438 125,000 -0- $10,266
and Chief Financial Officer 1993 $200,000 $129,742 (excl) -0- 7,200 -0- $8,764
- -----------------------------------------------------------------------------------------------------------------
MANUEL A. BAEZ (8) 1995 $307,000 $190,000 $ 561 -0- 23,700 -0- $15,483
Executive Vice President 1994 $288,007 $190,000 $ 4,571 -0- 125,000 -0- $14,068
1993 $264,200 $163,000 (excl) -0- 16,500 -0- $14,975
- -----------------------------------------------------------------------------------------------------------------
ARTHUR F. STAUBITZ 1995 $280,000 $216,500 $ 106 -0- 23,300 -0- $14,400
Senior Vice President 1994 $266,554 $200,000 (excl) $ 232,092 100,000 -0- $10,397
and General Counsel 1993 $239,840 $ 80,000 (excl) -0- 9,700 -0- $6,694
- -----------------------------------------------------------------------------------------------------------------
</TABLE>
8
<PAGE>
- --------------------------------------------------------------------------------
(1) Amounts shown include cash compensation earned by the named executive
officers during the year covered, including amounts deferred at the election
of those officers. Bonuses are paid in the year following the year during
which they are earned.
(2) As permitted by the Securities and Exchange Commission's (SEC) rules
regarding disclosure of executive compensation in proxy statements, this
column excludes perquisites and other personal benefits for the named
executive officer if their total cost in each of 1995, 1994 and 1993 did not
exceed the lesser of $50,000 or 10% of the total of annual salary and bonus
reported for the named executive officer for those years. Of the 1995 amount
shown for Mr. Loucks, $170,755 represents the approximate incremental cost
to the Company of his use of Company aircraft for personal travel, which the
Company required for security reasons.
(3) Amounts shown represent the market value at the date of grant, without
giving effect to the diminution in value attributable to the restrictions on
such stock. The amounts shown in this column include grants to the specified
named executive officers under the 1989 Long-Term Incentive Plan. The
restricted shares granted to Mr. Knight in 1995 under that Plan could be
earned based on 1996 performance and, if so, they would ordinarily vest on
December 31, 1997. The Plan is discussed in the Compensation Committee
report beginning on page 13. As of December 31, 1995, the number and value
of the aggregate restricted stock holdings of the named executive officers
are as follows: Mr. Loucks--130,911 shares ($5,481,898); Mr. Knight--22,000
shares ($921,250); Mr. White--(none); Mr. Kraemer--20,992 shares ($879,040);
Mr. Baez--31,442 shares ($1,316,634); and Mr. Staubitz--10,325 shares
($432,359). Dividends are payable on all outstanding shares of restricted
stock held by all Company executives at the same rate and time and in the
same form in which dividends are payable on all outstanding shares of Common
Stock, as required by the Company's 1987 Incentive Compensation Program.
(4) No Stock Appreciation Rights (SARs) were granted by the Company in 1995, and
there are no outstanding SARs held by any employee or director of the
Company. The number shown represents the number of shares of Common Stock
for which options were granted to the named executive officer.
(5) The SEC rules regarding disclosure of executive compensation in proxy
statements allow awards of restricted stock that are subject to
performance-based conditions on vesting, in addition to lapse of time and/or
continued service with the Company, to be reported as awards under a
long-term incentive plan ("LTIP"), instead of as restricted stock awards.
The rules define an LTIP as a plan providing compensation intended to serve
as incentive for performance to occur over a period longer than one fiscal
year. Restricted stock awards which are earned based on annual financial
performance cannot be reported as LTIP awards, even if, as in the case of
the restricted stock awards identified in the "Restricted Stock Awards"
column, the stock may not be earned and vested until the end of at least two
years.
(6) Amounts shown represent the Company matching contributions in the Company's
Incentive Investment Plan, a qualified section 401(k) profit sharing plan,
additional matching contributions in the Company's deferred compensation
plan and the dollar value of split-dollar life insurance benefits. Those
three amounts for 1995, expressed in the same order as identified above, for
the named executive officers are as follows: Mr. Loucks-- $4,500, $42,030,
and $2,580; Mr. Knight--$4,500, $18,510, and $231; Mr. White--$4,500,
$19,568, and $504; Mr. Kraemer--$4,500, $10,907, and $97; Mr. Baez--$4,500,
$10,410, and $573; and Mr. Staubitz--$4,500, $9,900, and $0.
(7) Mr. White ceased to be an officer of the Company on September 18, 1995. He
ceased to be an employee of the Company on December 31, 1995. In connection
with Mr. White's termination of employment, he and the Company negotiated a
separation agreement. The 1995 bonus shown for Mr. White was a payment made
to him, in accordance with the separation agreement, for satisfying his
obligation to assist the Company in the smooth transition of his
responsibilities to his successors. Mr. White's agreement is described on
page 11 of this proxy statement.
(8) Mr. Baez will cease to be an officer and an employee of the Company on May
3, 1996. In connection with Mr. Baez's anticipated termination of
employment, he and the Company negotiated a separation agreement. Mr. Baez's
agreement is described on page 12 of this proxy statement.
9
<PAGE>
- --------------------------------------------------------------------------------
STOCK OPTION GRANTS
The following table contains information relating to the stock option grants
made in 1995 under the Company's 1994 Incentive Compensation Program to the
named executive officers.
OPTION GRANTS TABLE
OPTION GRANTS IN LAST FISCAL YEAR(1)
<TABLE>
<CAPTION>
INDIVIDUAL GRANTS
-----------------------------------------
PERCENT OF
TOTAL POTENTIAL REALIZABLE VALUE
NUMBER OF OPTIONS AT ASSUMED ANNUAL RATES OF
SECURITIES GRANTED TO EXERCISE STOCK PRICE APPRECIATION
UNDERLYING EMPLOYEES OR BASE FOR OPTION TERM
OPTIONS IN FISCAL PRICE EXPIRATION --------------------------------------
NAME GRANTED(#) YEAR(2) ($/SH)(3) DATE 0%($) 5%($)(4) 10%($)(4)
<S> <C> <C> <C> <C> <C> <C> <C>
- ---------------------------------------------------------------------------------------------------------------------
Mr. Loucks 110,800 2.1% $37.25 7/29/05 $-0- $ 2,595,634 $ 6,577,853
Mr. Knight 44,800 0.9% $37.25 7/29/05 $-0- $ 1,049,498 $ 2,659,637
Mr. White 44,800 0.9% $37.25 3/29/96 (5) $-0- $ 1,049,498 $ 2,659,637
Mr. Kraemer 35,400 0.7% $37.25 7/29/05 $-0- $ 829,291 $ 2,101,588
Mr. Baez 23,700 0.5% $37.25 8/02/96 (5) $-0- $ 555,203 $ 1,406,996
Mr. Staubitz 23,300 0.4% $37.25 7/29/05 $-0- $ 545,833 $ 1,383,249
All Stockholders N/A N/A N/A N/A $-0- $6,369,603,169 $16,141,840,341
All Optionees 5,200,000 100.0% $37.25 7/29/05 $-0- $ 121,816,760 $ 308,707,880
Optionee Gain as % of
All Stockholders'
Gain N/A N/A N/A N/A N/A 1.9% 1.9%
- ---------------------------------------------------------------------------------------------------------------------
</TABLE>
(1) No Stock Appreciation Rights (SARs) were granted by the Company in 1995.
(2) In 1995, the Company granted options on approximately 5.2 million shares of
Common Stock to approximately 6,400 employees.
(3) The exercise price shown is the closing price of the Common Stock on the
date of grant, which was July 31, 1995.
(4) The amounts shown in these two columns represent the potential realizable
values using the options granted and the exercise price. The assumed rates
of stock price appreciation are set by the SEC proxy statement disclosure
rules and are not intended to forecast the future appreciation of the Common
Stock.
(5) The option expiration dates shown for Mr. White and Mr. Baez were
accelerated based on their employment termination dates and pursuant to the
option grant terms and conditions. The potential realizable value of their
stock option grants was calculated without regard to the accelerated
expiration dates.
(6) All options shown in this table become exercisable five years from the date
of grant, subject to accelerated vesting as follows. One hundred percent of
the option will become exercisable on the first business day after the
ninetieth consecutive calendar day during which the average fair market
value of the Common Stock equals or exceeds $50 per share. The exercise
price may be paid in cash or shares of Common Stock. The 1994 Program
provides that if specified corporate control changes occur, all outstanding
options will become exercisable immediately.
- --------------------------------------------------------------------------------
STOCK OPTION EXERCISES
The following table contains information relating to the exercise of stock
options by the named executive officers in 1995 as well as the number and value
of their unexercised options as of December 31, 1995.
10
<PAGE>
- --------------------------------------------------------------------------------
AGGREGATED OPTION EXERCISES IN LAST FISCAL YEAR
AND FISCAL YEAR-END OPTION VALUES(1)
<TABLE>
<CAPTION>
NUMBER OF SECURITIES UNDERLYING VALUE OF UNEXERCISED
UNEXERCISED OPTIONS AT FISCAL IN-THE- MONEY OPTIONS AT
YEAR-END(#)(2) FISCAL YEAR END($)(3)
SHARES ACQUIRED ON VALUE -------------------------------- --------------------------
NAME EXERCISE(#) REALIZED($) EXERCISABLE UNEXERCISABLE EXERCISABLE UNEXERCISABLE
<S> <C> <C> <C> <C> <C> <C>
- -----------------------------------------------------------------------------------------------------------------
Mr. Loucks -0- N/A 131,059 140,400 $1,708,460 $ 982,350
Mr. Knight -0- N/A 46,757 53,800 $ 619,426 $ 350,075
Mr. White 68,673 $ 1,087,600 -0- 44,800(4) $ -0 - $ 207,200
Mr. Kraemer -0- N/A 25,109 37,800 $ 430,094 $ 201,825
Mr. Baez -0- N/A 44,607 29,200 $ 672,466 $ 196,925
Mr. Staubitz -0- N/A 6,466 26,534 $ 102,648 $ 159,102
- -----------------------------------------------------------------------------------------------------------------
</TABLE>
(1) No Stock Appreciation Rights (SARs) were exercised by any Company employee
in 1995, and there are no outstanding SARs held by any employee or director
of the Company.
(2) The sum of the numbers under the Exercisable and Unexercisable columns of
this heading represents each named executive officer's total outstanding
options.
(3) The dollar amounts shown under the Exercisable and Unexercisable columns of
this heading represent the number of exercisable and unexercisable options,
respectively, which were "In-the-Money" on December 31, 1995, multiplied by
the difference between the closing price of the Common Stock on December 31,
1995, which was $41.875 per share, and the exercise price of the options.
For purposes of these calculations, In-the-Money options are those with an
exercise price below $41.875 per share.
(4) The 44,800 unexercisable options shown for Mr. White expire on March 29,
1996, in accordance with the normal option grant terms and conditions
relating to employment termination. Mr. White will forfeit those options
because they will not be exercisable prior to March 29, 1996.
- --------------------------------------------------------------------------------
LONG-TERM INCENTIVE PLANS
No long-term incentive plan table is included in this proxy statement
because no long-term incentive plan awards were made to any of the named
executive officers during 1995.
- --------------------------------------------------------------------------------
SEPARATION AGREEMENTS
Mr. White ceased to be an officer of the Company on September 18, 1995. He
ceased to be an employee of the Company on December 31, 1995. In connection with
Mr. White's termination of employment, he and the Company negotiated a
separation agreement. Under the agreement, Mr. White's monthly perquisite
allowances, equal to a total of $1,300 per month, and salary were paid to him
until December 31, 1995. The agreement allowed Mr. White to vest in 7,625 of the
restricted shares of Common Stock which he earned under the 1989 Long-Term
Incentive Plan for 1994 performance. The agreement specifies that Mr. White
forfeited 31,233 restricted shares of Common Stock, including an additional
7,500 shares which he earned under the 1989 Long-Term Incentive Plan for 1994
performance.
The agreement also provides Mr. White with 10 additional years of Pension
Plan participation through a non-qualified and unfunded supplemental pension
benefit. The additional years of Pension Plan participation are shown in the
information reported for Mr. White under the Pension Plan Table on page 17.
11
<PAGE>
- --------------------------------------------------------------------------------
Mr. Baez will cease to be an officer and an employee of the Company on May
3, 1996. In connection with Mr. Baez's anticipated termination of employment, he
and the Company negotiated a separation agreement. Under the agreement, Mr.
Baez's monthly perquisite allowances, equal to a total of $1,300 per month, and
salary will be paid to him until May 3, 1996. He also is eligible to receive a
pro-rated bonus, up to a maximum of $78,000, under the provisions of the 1996
Officer Incentive Compensation Plan. The agreement alows Mr. Baez to vest in the
8,316 restricted shares of Common Stock, which he earned under the 1989
Long-Term Incentive Plan for 1995 performance, and an additional 12,743
restricted shares of Common Stock, which represents a pro-rated portion of a
grant he received in 1992. The agreement specifies that Mr. Baez will forfeit
10,383 restricted shares of Common Stock on May 3, 1996.
The agreement also provides Mr. Baez with five additional years of Pension
Plan participation and five additional years of age through a non-qualified and
unfunded supplemental pension benefit. The additional years of Pension Plan
participation are shown in the information reported for Mr. Baez under the
Pension Plan table on page 17.
The other compensation and benefit elements of Mr. White's and Mr. Baez's
separation agreements are the same as those provided to all salaried employees
of the Company and its subsidiaries in the U.S. who receive separation
agreements. In exchange for the negotiated compensation and benefits included in
the separation agreements, Mr. White and Mr. Baez each gave the Company a
general waiver and release of all claims each may have against the Company and
its subsidiaries as well as their directors, officers and employees. Their
agreements also confirm their obligations under their non-compete and
confidentiality agreements with the Company.
- --------------------------------------------------------------------------------
COMPANY FINANCIAL PERFORMANCE
The following graph compares the performance of the Common Stock with the
Standard & Poor's 500 Composite Index and the Standard & Poor's Medical Products
and Supplies Index. The comparison of total return (change in year end stock
price plus reinvested dividends) for each of the years assumes that $100 was
invested on December 31, 1990 in each of the Company, the Standard & Poor's 500
Index and the Standard & Poor's Medical Index with investment weighted on the
basis of market capitalization. The 1992 Company dividend includes the Caremark
International Inc. stock dividend distributed on November 30, 1992.
12
<PAGE>
- --------------------------------------------------------------------------------
FIVE YEAR CUMULATIVE TOTAL RETURN
EDGAR REPRESENTATION OF DATA POINTS USED IN PRINTED GRAPHIC
<TABLE>
<CAPTION>
COMPANY S&P 500 MEDICAL INDEX*
<S> <C> <C> <C>
1990 100.0 100.0 100.0
1991 146.5 130.5 163.5
1992 132.9 140.6 140.1
1993 103.7 154.6 106.9
1994 125.2 156.6 126.8
1995 191.5 215.5 214.2
*S&P Medical Products and Supplies Index
</TABLE>
- --------------------------------------------------------------------------------
COMPENSATION COMMITTEE REPORT ON EXECUTIVE COMPENSATION
The compensation of the Company's executive officers is determined by the
Compensation Committee of the Board of Directors. The committee currently has
four members. As required by the Company's bylaws, the committee consists solely
of non-employee directors.
COMPENSATION PHILOSOPHY FOR EXECUTIVE OFFICERS
The committee's philosophy is to provide compensation opportunities
supporting the Company's values of respect for individuals, responsiveness to
customers and results for stockholders. Forms and levels of total compensation
are structured to be competitive when compared to other health-care companies
and to companies of similar size. These companies are reported in surveys whose
participants include most companies included in the Standard & Poor's Medical
Products and Supplies Index, as well as other companies with which the Company
and its subsidiaries compete for executive talent ("comparable companies"). This
philosophy is intended to assist the Company in attracting, retaining and
motivating executives with superior leadership and management abilities.
Consistent with this philosophy, the committee determines a total compensation
structure for each officer, including Mr. Loucks, consisting primarily of
salary, cash bonus, restricted stock, stock options and benefits. The
proportions of these elements of compensation vary among the officers depending
upon their levels of responsibility. The senior
13
<PAGE>
- --------------------------------------------------------------------------------
executive officers ordinarily receive a larger portion of their total
compensation through performance-based incentive plans, which place a greater
percentage of their compensation at risk while more closely aligning their
interests with the interests of the Company's stockholders.
The committee's philosophy with respect to the cap on the tax-deductibility
of executive compensation is to maximize the benefit of tax laws for the
Company's stockholders by seeking performance-based exemptions where consistent
with the Company's compensation policies and practices. The committee adopted
1995 and 1996 performance goals for the Company's officer cash bonus plan and
1989 Long-Term Incentive Plan which are expected to satisfy the deductibility
requirements with respect to any payments under those plans in 1996 and 1997.
COMPENSATION ELEMENTS
The committee establishes salaries each year at a level primarily intended
to be competitive at the 50th percentile with salaries of executive officers in
comparable companies. In addition, officer salaries are based on the officer's
individual performance. Actual salaries in a number of cases are under the 50th
percentile due to the Company's commitment to controlling costs and its practice
of adjusting salaries over time rather than immediately when there are
promotions into senior executive positions.
Bonuses are intended to provide executive officers with an opportunity to
receive additional cash compensation (which when combined with salary provides
total cash compensation between the 50th and 75th percentile of total cash
compensation paid to executives in comparable companies), but only if they earn
it through the Company's achievement of strong performance results as measured
by net income growth and operational cash flow. Each year, the committee
establishes a bonus range for each executive officer by utilizing the market
data of comparable companies. After year-end results are reported, the committee
determines each officer's bonus based on individual performance and the
Company's performance against the net income growth and operational cash flow
goals it established for the year. The Company outperformed its net income
growth and operational cash flow goals for 1995. For example, the Company's
actual operational cash flow for 1995 was 117 percent of its operational cash
flow goal. Consequently, actual bonuses for 1995 ranged from 85 percent to 100
percent of the high end of the executive officers' respective bonus ranges.
Restricted stock has been granted, under the Company's 1989 Long-Term
Incentive Plan, to maintain the plan period through 1996. This plan was
established as part of the Company's 1987 Incentive Compensation Program ("1987
Program"), which was approved by the Company's stockholders in 1987. Restricted
stock grants are intended to be a mechanism for aligning management's and
stockholders' interests. The plan provides participants the opportunity to build
equity in the Company if the Company achieves strong performance as measured by
net income growth and operational cash flow as well as by comparing the annual
percentage change in the Company's stock price to the annual percentage change
in the Standard & Poor's Medical Products & Supplies Index. Each participant has
a targeted number of restricted shares that can be earned annually if the
Company achieves its net income growth and operational cash flow goals. The
amount earned is then adjusted upward or downward based on the Company's total
rate of return to stockholders compared to the percentage change in the Standard
& Poor's Medical Products and Supplies Index. The number of restricted shares
granted is determined based upon the number of restricted shares which each
executive officer would earn if the Company achieved its annual net income
growth and operational cash flow goals. The stock ordinarily vests one year
after it is earned, provided the participant remains employed by the Company or
one of its subsidiaries. Because of the Company's annual net income growth and
14
<PAGE>
- --------------------------------------------------------------------------------
operational cash flow in 1995, and because of the Company's 1995 total rate of
return to stockholders relative to the percentage change in the Standard &
Poor's Medical Products and Supplies Index, 154 percent of restricted share
targets were earned under the plan for 1995.
Stock options are granted under the Company's 1994 Incentive Compensation
Program ("1994 Program"), which was approved by the Company's stockholders in
1994. They represent an additional vehicle for aligning management's and
stockholders' interests, specifically motivating executives to remain focused on
the market value of the Common Stock in addition to net income growth and
operational cash flow goals. Options are granted with an exercise price equal to
the fair-market value of the Common Stock on the day of the grant. In 1995, the
committee granted stock options on approximately 5.2 million shares of Common
Stock to approximately 6,400 employees of the Company and its subsidiaries.
Beginning with 1995, it is the committee's intention to make broad-based stock
option grants biannually, rather than annually, as it has in the past.
The Company implemented the Shared Investment Plan in 1994 to align further
management's interests with the interests of stockholders and continue to tie
management incentives to stockholder value. The Plan provided the 63 top members
of the Company's management with a one day option to purchase a significant
amount of Common Stock. The six named executive officers voluntarily took out
full-recourse, personal loans to buy $28,600,000 worth (1,100,000 shares) of
Common Stock on June 15, 1994. This is one of the strongest statements our
management team has made about their personal commitment to increasing
stockholder value. The transaction increased key employees' motivation to manage
the Company as owners. To a significant degree, their financial well-being will
depend heavily on the performance of the Common Stock.
The number of restricted shares and options ordinarily granted to executive
officers is formula-driven. The formula is designed to provide an opportunity to
earn stock-based compensation (half in restricted stock, half in options) at a
third-quartile level compared to executives in comparable companies. The grants
of restricted stock are based on the value of the Common Stock at the date of
grant. The grants of stock options are based on an estimated appreciation in the
Common Stock over time discounted to a present value. When the Company grants
restricted stock under the 1989 Long-Term Incentive Plan and stock options, it
considers approaches taken by comparable companies, to the extent those
approaches are consistent with the Company's total compensation philosophy and
its performance against established goals.
MR. LOUCKS' 1995 COMPENSATION
Mr. Loucks participates in the same compensation plans provided to other
executive officers. The committee's general approach to setting Mr. Loucks'
compensation is to be competitive with comparable companies--and to have a
majority of his compensation dependent on achievement of performance criteria
established by the committee and the performance of the Common Stock. All
compensation actions relating to Mr. Loucks are subject to the approval of the
Board of Directors. The actions described in this report have been approved.
Mr. Loucks' salary had most recently been established in 1991, based upon an
analysis of competitive compensation data. In February 1992, the committee
capped Mr. Loucks' salary at $751,000, its 1991 level, and capped his bonus at
$800,000, its 1990 level, for the five-year period beginning in 1992. Mr.
Loucks' salary and bonus were capped for the five-year period, and the committee
granted Mr. Loucks 65,000 shares of restricted stock in lieu of the salary and
cash bonus increases he might have otherwise received over that five-year
period, because of the
15
<PAGE>
- --------------------------------------------------------------------------------
committee's continuing emphasis on aligning management's and stockholders'
interests. The committee determines the number of shares earned on an annual
basis, based on its assessment of Mr. Loucks' performance for that particular
year. All earned shares are scheduled to vest on December 31, 1997, if he
remains employed by the Company or one of its subsidiaries on that date.
In September 1993, Mr. Loucks requested and was granted a 25 percent salary
reduction as a demonstration of his personal commitment to controlling costs and
improving the Company's operating performance. A reduced salary continued
throughout 1994. In January 1995, Mr. Loucks' salary was restored to its 1991
level. Recently, the committee determined that Mr. Loucks earned 17,000 of the
65,000 shares of restricted stock for 1995, based on the Company's strong
operating performance and because the Company achieved a total rate of return to
stockholders of 53 percent for 1995. The committee also determined that Mr.
Loucks earned an $800,000 bonus because the Company exceeded its net income
growth and operational cash flow goals for 1995. The Company's success in 1995
reflects Mr. Loucks' continued commitment to the strategic direction of the
Company toward an objective of leadership in health care and his guidance of the
Company through a particularly turbulent and challenging environment in U.S.
health care.
Under the Company's Shared Investment Plan, Mr. Loucks purchased 350,000
shares of Common Stock. As described above, this purchase by Mr. Loucks and
other executive officers reinforces the link between management's and
stockholders' interests.
Mr. Loucks, like other participants in the 1989 Long-Term Incentive Plan,
was deemed to have earned 154 percent of his annual target award of restricted
stock in 1995, based on the Company's strong net income growth, operational cash
flow and Common Stock performance for 1995.
RELATIONSHIP OF EXECUTIVE COMPENSATION TO COMPANY PERFORMANCE
The committee believes that management should be motivated, and compensated,
based on the Company's financial and Common Stock performance. For this reason,
the committee has emphasized goals for net income growth, operational cash flow
and Common Stock performance when determining cash bonus and long-term incentive
compensation for all executive officers, as explained above. The committee
believes that strong financial performance, as expressed by net income growth,
operational cash flow and Common Stock performance, were the appropriate focus
for 1995. The common stock returns improved in 1995 in spite of the pressure on
health-care costs and uncertainty over the direction of U.S. health-care reform.
The Company surpassed its financial performance goals again this year and
achieved a total rate of return to stockholders of 53 percent for 1995. Also,
the Company's market value increased over $3.7 billion during that period.
<TABLE>
<S> <C>
Silas S. Cathcart (Chairman)
Mary Johnston Evans Martha R. Ingram
Georges C. St. Laurent, Jr.
</TABLE>
16
<PAGE>
- --------------------------------------------------------------------------------
PENSION PLAN, EXCESS PLANS AND SUPPLEMENTAL PLANS
The following table shows estimated annual retirement benefits payable to
participants in the Company's United States pension plan ("Pension Plan") whose
employment terminates at normal retirement (age 65). The normal retirement
benefit equals 1.75% of the average of an employee's five highest consecutive
calendar years of earnings out of his or her last ten calendar years of earnings
("Final Average Pay"), multiplied by the employee's years of Pension Plan
participation. In general, the earnings covered by the Pension Plan include
salary, annual cash bonuses and other regular pay. The figures shown include
benefits payable under the Pension Plan, the Company's related defined benefit
excess pension plan and supplemental plans for certain individuals. The
estimates assume that benefit payments begin at age 65 under a single life
annuity form. The figures are net of the Social Security offset specified by the
Pension Plan's benefit formula and therefore do not include Social Security
benefits payable from the federal government. The primary Social Security amount
used in the calculations is that payable for an individual attaining age 65 in
1995.
Although age 65 is the normal retirement age under the Pension Plan, the
Pension Plan has early retirement provisions based on a point system. Under the
point system, each participant is awarded one point for each year of Pension
Plan participation and one point for each year of age. Participants who
terminate employment after accumulating 65 points, and who wait to begin
receiving their Pension Plan benefits until they have 85 points, receive the
same Pension Plan benefits they would otherwise receive at age 65, regardless of
their actual age when they begin receiving their Pension Plan benefits.
PENSION PLAN TABLE
<TABLE>
<CAPTION>
ESTIMATED ANNUAL RETIREMENT BENEFITS
--------------------------------------------------------
YEARS OF PENSION PLAN PARTICIPATION(1)
FINAL AVERAGE --------------------------------------------------------
PAY(1) 15 20 25 30 35
<S> <C> <C> <C> <C> <C> <C> <C>
- ----------------------------------------------------------------------------------------------------------
$ 200,000 $ 48,600 $ 64,800 $ 81,000 $ 97,200 $ 113,500
300,000 74,800 99,800 124,700 149,700 174,800
400,000 101,100 134,800 168,500 202,200 236,000
500,000 127,300 169,800 212,200 254,700 297,300
600,000 153,600 204,800 256,000 307,200 358,500
700,000 179,800 239,800 299,700 359,700 419,800
800,000 206,100 274,800 343,500 412,200 481,000
900,000 232,300 309,800 387,200 464,700 542,300
1,000,000 258,600 344,800 431,000 517,200 603,500
1,100,000 284,800 379,800 474,700 569,700 664,800
1,200,000 311,100 414,800 518,500 622,200 726,000
1,300,000 337,300 449,800 562,200 674,700 787,300
1,400,000 363,600 484,800 606,000 727,200 848,500
1,500,000 389,800 519,800 649,700 779,700 909,800
1,600,000 416,100 554,800 693,500 832,200 971,000
1,700,000 442,300 589,800 737,200 884,700 1,032,300
1,800,000 468,600 624,800 781,000 937,200 1,093,500
1,900,000 494,800 659,800 824,700 989,700 1,154,800
- ----------------------------------------------------------------------------------------------------------
</TABLE>
(1) As of January 1, 1996, the named executive officers' years of Pension Plan
participation and Final Average Pay for purposes of calculating annual
retirement benefits payable under the Pension Plan are as follows: Mr.
Loucks--29 years and $1,440,808; Mr. Knight--13 years and $538,702; Mr.
White--35 years and $653,612; Mr. Kraemer--12 years and $325,371; Mr.
Baez--26 years and $462,387; and Mr. Staubitz--15 years and $351,225.
17
<PAGE>
- --------------------------------------------------------------------------------
The 35 years of Pension Plan participation shown for Mr. White includes the
ten additional years which he received through the non-qualified pension
supplement incorporated in his separation agreement described on page 11. The
calculation of his Final Average Pay, equal to $653,612, includes the $300,000
bonus which he received for satisfying his obligation to assist the Company in
the smooth transition of his responsibilities to his successors, and that Final
Average Pay will be used to calculate his pension supplement.
The 26 years of Pension Plan participation shown for Mr. Baez includes the
five additional years which he received through the non-qualified pension
supplement incorporated in his separation agreement described on page 12. In
addition to crediting him with five additional years of service, the pension
supplement credits Mr. Baez with five additional years of age. The additional
years of age will be used to calculate the amount of Mr. Baez's early retirement
benefit if he elects to begin receiving his pension benefit before he has 85
points and before he reaches age 65.
- --------------------------------------------------------------------------------
SECTION 16 REPORTING
Section 16 of the Securities Exchange Act of 1934 requires the Company's
executive officers and directors to report to the Securities and Exchange
Commission their ownership of the Company's equity securities when they are
first elected, and to report subsequent changes in their ownership. In February
1995, Donald W. Joseph, an executive officer of one of the Company's principal
subsidiaries, timely filed a Form 4 intended to report all previously unreported
1994 transactions, in the ordinary course of year-end reporting. In June 1995,
Mr. Joseph filed an amendment to that Form 4 to report a 1994 stock option grant
to his spouse for 600 shares of Common Stock. The stock option grant was
inadvertently omitted from his previously filed Form 4.
- --------------------------------------------------------------------------------
OWNERSHIP OF COMPANY SECURITIES
The following tables and footnotes show, as of February 23, 1996,
information to the best of the Company's knowledge with respect to the persons
who beneficially owned more than five percent of the Company's Common Stock as
well as information as to the Common Stock beneficially owned by each director
and named executive officer and by all directors and executive officers of the
Company as a group. The information relating to directors and named executive
officers is furnished by the respective directors and officers. For purposes of
this disclosure, the Securities and Exchange Commission has defined "beneficial
ownership" to include securities over which the individual has sole or shared
investment or voting power regardless of the economic incidents of ownership.
The amounts shown indicate the number of outstanding shares of Common Stock
beneficially owned by each director and named executive officer and all
directors and executive officers as a group, and include shares of Common Stock
beneficially owned under the Company's Incentive Investment Plan, a qualified
Section 401(k) profit sharing plan (the Plan amounts are included as of January
31, 1996, the latest information reasonably available). There are no outstanding
equity securities of the Company other than its Common Stock. No director or
named executive officer beneficially owned more than 1.0% of the outstanding
Common Stock. All directors and executive officers as a group own 1.5% of the
outstanding shares of Common Stock. Where a director or executive officer has
the right to acquire shares of Common Stock within 60 days after February 23,
1996, through the exercise of stock options or participation in the
18
<PAGE>
- --------------------------------------------------------------------------------
Company's employee stock purchase plans, these shares of Common Stock are
treated as beneficially owned by the individual and as outstanding for purposes
of computing the percentages owned by the individual and the group.
<TABLE>
<CAPTION>
SHARES OF
COMMON STOCK
BENEFICIALLY RIGHT TO
NAME OR GROUP OWNED ACQUIRE (1)
<S> <C> <C>
- --------------------------------------------------------------
FMR Corp. 20,475,829 (2) --
Manuel A. Baez 205,698 44,607
Silas S. Cathcart 3,334 --
Pei-yuan Chia 4,380 --
John W. Colloton 3,739 --
Susan Crown 13,000 (3) --
Mary Johnston Evans 7,134 --
Frank R. Frame 4,378 --
David W. Grainger 32,500 --
Martha R. Ingram 32,000 --
Lester B. Knight 281,742 46,757
Harry M. Jansen Kraemer, Jr. 188,036 25,389
Arnold J. Levine 6,270 1,570
Vernon R. Loucks Jr. 654,015 131,339
Georges C. St. Laurent, Jr. 250,940 --
Arthur F. Staubitz 129,296 6,716
Monroe E. Trout 5,100 --
Reed V. Tuckson -- --
Fred L. Turner 5,539 --
Tony L. White 245,485 --
All directors and executive
officers as a group (4) 4,134,402 711,587
- --------------------------------------------------------------
</TABLE>
(1) The shares indicated under Right to Acquire are included under Shares of
Common Stock Beneficially Owned.
(2) Based upon information as of December 31, 1995 set forth in a Schedule 13G
filing made by FMR Corp. and dated February 14, 1996. This number of shares
represents approximately 7.5% of the outstanding shares of Common Stock. FMR
Corp.'s address is 82 Devonshire Street, Boston, Massachusetts 02109.
(3) Ms. Crown disclaims beneficial ownership of 5,000 shares.
(4) Adjustments are made to avoid double counting of shares as to which more
than one beneficial owner is listed.
- --------------------------------------------------------------------------------
19
<PAGE>
- --------------------------------------------------------------------------------
Except as indicated in the following table, the shares of Common Stock shown
above are held with sole power over both investment and voting.
<TABLE>
<CAPTION>
- -------------------------------------------------------------------
VOTING POWER INVESTMENT POWER
NAME SHARED SHARED
- -------------------------------------------------------------------
<S> <C> <C>
Manuel A. Baez 300 300
Susan Crown 5,000 5,000
Lester B. Knight 260 260
Harry M. Jansen Kraemer, Jr. 16,485 16,485
Arthur F. Staubitz 12,255 12,255
Monroe E. Trout 1,000 1,000
Tony L. White 22,363 22,363
All directors and executive
officers as a group 142,952 142,952
- -------------------------------------------------------------------
</TABLE>
PROPOSAL TO RATIFY APPOINTMENT OF INDEPENDENT ACCOUNTANT
(ITEM 2 ON PROXY CARD)
The Board of Directors has reappointed Price Waterhouse LLP as independent
accountant for the Company in 1996. The board recommends that the appointment be
ratified. If the resolution is not adopted, the board will consider the
selection of another public accounting firm for 1996 and future years.
Fees for services performed by Price Waterhouse LLP during 1995 related to
the audit of the consolidated annual financial statements, including statutory
audits of foreign subsidiaries, aggregated approximately $2.9 million. In
addition to the audit of the consolidated financial statements, Price Waterhouse
LLP performed other audit related services including: audits of employee benefit
plans, limited reviews of quarterly financial information, reviews of officers'
compensation, assistance with regulatory filings, acquisition and divestiture
reviews, and consultations in connection with various financial reporting and
accounting matters. Fees for these other audit related services aggregated
approximately $0.7 million while fees for other consulting services aggregated
approximately $1.7 million.
A representative of Price Waterhouse LLP will attend the annual meeting and
will be prepared to respond to questions. The representative may make a
statement at the meeting if he or she so desires.
The Board of Directors recommends a vote FOR ratification of the selection
of Price Waterhouse LLP as independent accountant for 1996.
- --------------------------------------------------------------------------------
CURRENT STOCKHOLDER PROPOSAL
The Company has been informed that the following stockholder proposal will
be presented for a vote at the 1996 annual meeting of stockholders. The Board of
Directors recommends a vote AGAINST the proposal; its reasons follow the
stockholder's proposal and supporting statement.
20
<PAGE>
- --------------------------------------------------------------------------------
STOCKHOLDER PROPOSAL RELATING TO CUMULATIVE VOTING IN THE ELECTION OF DIRECTORS
(ITEM 3 ON PROXY CARD)
The Company has been advised that Margaret R. and/or John J. Gilbert, 29
East 64th Street, New York, New York 10021-7043, as co-trustees under the will
of Minnie D. Gilbert and as beneficial owners of 100 shares of Common Stock,
and/or Martin Glotzer, 7061 N. Kedzie, Chicago, Illinois 60645, as the owner of
50 shares of Common Stock will have the following resolution presented at the
annual meeting:
RESOLVED: That the stockholders of Baxter International Inc., assembled in
annual meeting in person and by proxy, hereby request the Board of Directors to
take the steps necessary to provide for cumulative voting in the election of
directors, which means each stockholder shall be entitled to as many votes as
shall equal the number of shares he or she owns multiplied by the number of
directors to be elected, and he or she may cast all of such votes for a single
candidate, or any two or more of them as he or she may see fit.
STOCKHOLDER'S STATEMENT SUPPORTING THE PROPOSED RESOLUTION
Continued very strong support along the lines we suggest were shown at the
last annual meeting when 34.2%, 5,818 owners of 74,219,285 shares, were cast in
favor of this proposal. The vote against included 179 unmarked proxies.
A California law provides that all state pension holdings and state college
funds, invested in shares must be voted in favor of cumulative voting proposals,
showing increasing recognition of the importance of this democratic means of
electing directors.
The National Bank Act provides for cumulative voting. In many cases
companies get around it by forming holding companies without cumulative voting.
Banking authorities have the right to question the capability of directors to be
on banking boards. In many cases authorities come in after and say the director
or directors were not qualified. We were delighted to see the SEC has finally
taken action to prevent bad directors from being on boards of public companies.
The SEC should have hearings to prevent such persons from becoming directors
before they harm investors.
We think cumulative voting is the answer to find new directors for various
committees. Some recommendations have been made to carry out the CERES 10
points. The 11th should be, in our opinion, having cumulative voting and ending
staggered boards.
When Alaska became a state it took away cumulative voting over our
objections. The Valdez oil spill might have been prevented if environmental
directors were elected through cumulative voting. The huge derivative losses
might have also been prevented with cumulative voting.
Many successful corporations have cumulative voting. Example, Pennzoil
defeated Texaco in that famous case. Ingersoll-Rand also having cumulative
voting won two awards. FORTUNE magazine ranked it second in its industry as
"America's Most Admired Corporations" and the WALL STREET TRANSCRIPT noted "on
almost any criteria used to evaluate management, Ingersoll-Rand excels." In 1994
and 1995 they raised their dividend.
Lockheed-Martin, as well as VWR Corporation now have a provision that if
anyone has 40% of the shares, cumulative voting applies.
In 1995 American Premier adopted cumulative voting. Allegheny Power System
tried to take away cumulative voting, as well as put in a stagger system, and
stockholders defeated it, showing stockholders are interested in their rights.
21
<PAGE>
- --------------------------------------------------------------------------------
If you agree, please mark your proxy for this resolution; otherwise it is
automatically cast against it, unless you have marked to abstain.
- --------------------------------------------------------------------------------
BOARD OF DIRECTORS' STATEMENT OPPOSING STOCKHOLDER RESOLUTION
For the reasons explained below, the Board of Directors believes that
cumulative voting for directors would not serve the best interests of the
Company and its stockholders. The board recommends a vote AGAINST the proposed
resolution.
Directors should be elected based on their ability and commitment to
represent the best interests of the Company and its stockholders as a whole.
This tenet is best served when each director is elected by a majority vote of
the stockholders. Cumulative voting can enable, and indeed encourage, a
relatively small special-interest group to elect one or more directors.
Directors so elected might feel compelled to act in the interest of the group
that elected them rather than in the interest of all stockholders.
Cumulative voting introduces the possibility of partisanship among board
members, which could undermine the ability of the board to work together
effectively. The variety and complexity of issues facing the Company
necessitates that no actual or apparent influence bring into question the
objectivity of the board's insight, perspective or counsel.
The board encourages stockholders to present director candidates to the
board's Planning and Organization Committee, which assists and advises the board
in connection with board membership. Notably, the Planning and Organization
Committee consists solely of non-employee directors. A summary of the process by
which stockholders may present director candidates is included in the
description of the Planning and Organization Committee on page 6 of this proxy
statement.
In the board's opinion, the present method of electing directors, where each
director is elected by majority vote of all stockholders, best assures that the
directors will guide the affairs of the Company for the benefit of all
stockholders.
The board recommends a vote AGAINST cumulative voting in the election of
directors.
- --------------------------------------------------------------------------------
FUTURE STOCKHOLDER PROPOSALS
From time to time stockholders present proposals which may be proper
subjects for inclusion in the proxy statement and for consideration at the
annual meeting. To be included in the proxy statement for the 1997 annual
meeting, proposals must be received by the Company no later than November 25,
1996.
Stockholders may present proposals which are proper subjects for
consideration at an annual meeting, even if the proposal is not submitted by the
deadline for inclusion in the proxy statement. To do so, the stockholder must
comply with the procedures specified by the Company's bylaws. The Company's
bylaws require all stockholders who intend to make proposals at an annual
stockholders meeting to submit their proposals to the Company 60 to 90 days
before the anniversary date of the previous year's annual meeting. To be
eligible for consideration at the 1997 annual meeting, proposals which have not
been submitted by the deadline for inclusion in the proxy statement must be
received by the Company between February 6 and March 7, 1997. The provision is
intended to allow all stockholders to have an opportunity to consider business
expected to be raised at the meeting.
22
<PAGE>
- --------------------------------------------------------------------------------
COST OF PROXY SOLICITATION
The Company will bear the costs of soliciting proxies. In addition to use of
the mails, proxies may be solicited by directors, officers and employees of the
Company personally, by telephone or by telegram. Such persons will not be
specially compensated for such solicitation. The Company will request banks and
brokers to solicit their customers who have Common Stock registered in their
names or the names of their nominees and will reimburse such banks and brokers
for their reasonable out-of-pocket costs.
In addition, the Company has retained Georgeson & Co. Inc., 88 Pine Street,
New York, New York 10005 to aid in soliciting proxies from brokers, bank
nominees and other institutional owners by personal interview, telephone,
telegram or mail. The Company will pay Georgeson & Co. Inc. $12,500 for
stockholder solicitation and distribution of proxy materials and will reimburse
it for expenses.
- --------------------------------------------------------------------------------
OTHER BUSINESS
The Company is not aware of any business to be presented at the annual
meeting other than the matters described above. If a stockholder vote is
necessary to transact any other business at the meeting, the proxyholders intend
to vote their proxies in accordance with their best judgment related to such
business.
By order of the Board of Directors,
[signature]
A. GERARD SIECK
SECRETARY
Deerfield, Illinois
March 22, 1996
23
<PAGE>
PROXY
[BAXTER LOGO] PROXY FOR ANNUAL MEETING OF STOCKHOLDERS-MAY 6, 1996
Baxter
International Inc. Solicited by the Board of Directors of Baxter
One Baxter Parkway International Inc.
Deerfield, IL 60015
708-948-2000 The undersigned hereby appoint(s) Vernon R. Loucks
Jr. and Arthur F. Staubitz or either of them, with
full power of substitution, as proxyholders to
represent and to vote, as designated on the reverse
hereof, the common stock of the undersigned
(including any shares of common stock credited under
the Company's Stockholder Investment Service or
uncertificated share account of the employee stock
purchase plans) at the annual meeting of the
stockholders of the Company to be held on May 6, 1996
and at any adjournment thereof.
Election of Director,
Nominees: Comments/Change of Address
Silas S. Cathcart ___________________________
David W. Grainger ___________________________
Martha R. Ingram ___________________________
Harry M. Jansen
Kraemer, Jr. ___________________________
Reed V. Tuckson, M.D. ___________________________
Fred L. Turner ___________________________
You are encouraged to specify your choices by marking
the appropriate boxes. SEE REVERSE SIDE. You need not
mark any boxes if you wish to vote in accordance with
the Board of Directors' recommendations. The
proxyholders named above cannot vote your shares
unless you sign and return this card. Please mark,
sign and date this proxy card and mail it in the
envelope provided.
--------------
SEE REVERSE SIDE
--------------
<PAGE>
[X] Please mark your votes as in this example.
This proxy when properly executed will be voted in the manner directed
herein. If no direction is made, this proxy will be voted FOR election of
directors, FOR proposal 2 and AGAINST proposal 3.
- ---------------------------------------------------------------
The Board of Directors recommends a vote FOR proposals 1 and 2.
- ---------------------------------------------------------------
1. Election of Directors (See Reverse). [ ] FOR [ ] WITHHELD
For, except vote withheld from the following nominee(s):
_______________________________________________________
2. Ratification of independent accountants. [ ] FOR [ ] AGAINST [ ] ABSTAIN
- -----------------------------------------------------------
The Board of Directors recommends a vote AGAINST proposal 3.
- -----------------------------------------------------------
3. Proposal relating to cumulative voting [ ] FOR [ ] AGAINST [ ] ABSTAIN
in the election of directors.
__________________________________________________________
Treat votes as confidential. [ ]
Mark the box if you will attend the Annual Meeting [ ]
Mark the box if you have more than one [ ]
account and want to discontinue receiving
multiple copies of future annual reports.
SIGNATURE(S) ____________________DATE _________ The signer hereby revokes all
NOTE: Please sign exactly as name appears proxies heretofore given by
hereon. Joint owners should each sign. When the signer to vote at said
signing as attorney, executor, administrator, meeting or any adjournment
trustee or guardian, plese give full title as thereof.
such.
